Cargando…

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis

BACKGROUND: Multiple sclerosis (MS) affects about three times more women than men. Due to variable MS courses, multiple therapies are necessary in clinical practice. OBJECTIVE: We aimed at conducting sex-specific analyses of MS patients regarding polypharmacy (≥ 5 drugs) and at identifying differenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frahm, Niklas, Hecker, Michael, Zettl, Uwe Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537438/ https://www.ncbi.nlm.nih.gov/pubmed/31133051 http://dx.doi.org/10.1186/s13293-019-0243-9

Ejemplares similares

Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study
por: Frahm, Niklas, et al.
Publicado: (2019)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors
por: Frahm, Niklas, et al.
Publicado: (2019)

Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis
por: Langhorst, Silvan Elias, et al.
Publicado: (2022)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis
por: Bühring, Jan, et al.
Publicado: (2021)

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
por: Haker, Marie-Celine, et al.
Publicado: (2023)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022)

Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms
por: Freiesleben, Sherry, et al.
Publicado: (2016)

Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis
por: Frahm, Niklas, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
por: Frahm, Niklas, et al.
Publicado: (2022)

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2021)

Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes
por: Hecker, Michael, et al.
Publicado: (2021)

Aggressive multiple sclerosis: a matter of measurement and timing
por: Ellenberger, David, et al.
Publicado: (2020)

Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
por: Thamilarasan, Madhan, et al.
Publicado: (2013)

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis
por: Beiske, Georg Anton Giæver, et al.
Publicado: (2015)

Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2020)

Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
por: Putscher, Elena, et al.
Publicado: (2022)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
por: Hecker, Michael, et al.
Publicado: (2013)

Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance
por: Hundeshagen, Alexander, et al.
Publicado: (2012)

Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2011)

Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2021)

Polypharmacy and multiple sclerosis: A population-based study
por: Chertcoff, Anibal, et al.
Publicado: (2022)

Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study
por: Frahm, Niklas, et al.
Publicado: (2023)

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study
por: Blechinger, Stephan, et al.
Publicado: (2021)

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
por: Frahm, Niklas, et al.
Publicado: (2022)

Headaches in Multiple Sclerosis Patients Might Imply an Inflammatorial Process
por: Möhrke, Jan, et al.
Publicado: (2013)

Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis
por: Hecker, Michael, et al.
Publicado: (2022)

Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy
por: Hecker, Michael, et al.
Publicado: (2023)

The pathophysiology of motor fatigue and fatigability in multiple sclerosis
por: Patejdl, Robert, et al.
Publicado: (2022)

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
por: Friess, Jörg, et al.
Publicado: (2017)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Comparative evaluation of patients’ and physicians’ satisfaction with interferon beta-1b therapy
por: Zettl, Uwe Klaus, et al.
Publicado: (2016)

A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene
por: Hecker, Michael, et al.
Publicado: (2019)

Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care
por: Jalusic, Kris Oliver, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vlg1tn6lc3mmfsftl0f632pdd9